TP53 and metastatic prostate carcinoma: More recently, deep whole genome analysis of castrate resistant metastatic prostate carcinoma also identified structural variants in tumor suppressor genes including TP53, PTEN, RB1, CDKN1B and CHD1 resulting in biallelic gene inactivation, novel gene fusions and tandem gene duplications.